January update

Posted on: Thursday, January 25, 2018

Following my appointment to Strategic Partnership Manager in July 2016 I took on the role of Interim Executive Director of the Thames Valley Clinical Trials Unit in July 2017. It's has been a busy and fruitful period with many new projects in discussion or in the pipeline. I am pleased to share with you some the successes of the TVCTU since it's official launch in May 2017.

We recruited two leading researchers from the University of Reading to the Early Years Provision in Children’s Centres (EPICC) study, the first project to involve the CTU from concept. We now have dedicated Trial Management support for grant application and development. We've also appointed a dedicated, senior clinical research statistician (starting March 2018) who comes with a wealth of experience across a wide range of settings and theme areas. The first patient has been recruited to the first Royal Berkshire Hospital/University of Reading commercially funded collaboration involving the CTU.

I am delighted that integration of the Research and Development team from Berkshire Healthcare NHS Foundation Trust, the local community and mental health trust, into the CTU team has been swift with existing areas of common interest between the three partnership institutions being strengthened. Further new links are established, maintaining the CTU’s drive to focus on multi-disciplinary, translational research at all stages of the research pathway from lab-bench to implementation in patient groups.

Alongside this, a significant pipeline of grant applications have been submitted across a diverse array of themes including colorectal biology, cardiac rehabilitation, osteoarthritis, anxiety in bipolar disorder, child anxiety, Down’s syndrome, adolescent depression and mild cognitive impairment. This breadth demonstrates the diverse interests the CTU has the skillsets to facilitate these projects. Exciting times are ahead in 2018 and beyond, and I look forward to reporting on further successes in the future.